Boston Financial Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$41M Sell
199,454
-3,528
-2% -$774K 1.24% 20
2024
Q3
$49.2M Sell
202,982
-2,755
-1% -$644K 1.47% 15
2024
Q2
$45.2M Sell
205,737
-2,209
-1% -$480K 1.44% 15
2024
Q1
$46.8M Buy
207,946
+2,681
+1% +$605K 1.49% 18
2023
Q4
$45.1M Sell
205,265
-7,519
-4% -$1.59M 1.53% 14
2023
Q3
$46.7M Sell
212,784
-3,469
-2% -$785K 1.75% 14
2023
Q2
$48.7M Sell
216,253
-5,857
-3% -$1.17M 1.76% 14
2023
Q1
$42.5M Buy
222,110
+31
+0% +$5.99K 1.66% 17
2022
Q4
$41M Sell
222,079
-442
-0.2% -$77.7K 1.65% 17
2022
Q3
$37M Buy
222,521
+10,370
+5% +$2.11M 1.61% 19
2022
Q2
$43.7M Buy
212,151
+50
+0% +$11.3K 1.89% 14
2022
Q1
$51.3M Sell
212,101
-4,986
-2% -$1.16M 1.95% 14
2021
Q4
$52.8M Sell
217,087
-2,201
-1% -$503K 1.92% 14
2021
Q3
$44.8M Sell
219,288
-5,917
-3% -$1.27M 1.82% 16
2021
Q2
$46.5M Buy
225,205
+1,657
+0.7% +$334K 1.88% 16
2021
Q1
$42.6M Buy
223,548
+756
+0.3% +$140K 1.87% 16
2020
Q4
$42.2M Buy
222,792
+2,639
+1% +$492K 1.92% 16
2020
Q3
$38.8M Buy
220,153
+5,144
+2% +$822K 1.89% 17
2020
Q2
$33M Buy
215,009
+6,847
+3% +$1.04M 1.77% 18
2020
Q1
$29.1M Buy
208,162
+68,353
+49% +$10.2M 1.87% 16
2019
Q4
$21.3M Sell
139,809
-105
-0.1% -$15.4K 1.17% 27
2019
Q3
$20.2M Buy
139,914
+5,237
+4% +$783K 1.15% 30
2019
Q2
$20.1M Sell
134,677
-1,056
-0.8% -$141K 1.16% 27
2019
Q1
$17.4M Buy
135,733
+5,418
+4% +$638K 1.06% 32
2018
Q4
$13.9M Buy
130,315
+5,375
+4% +$600K 0.96% 36
2018
Q3
$14.3M Buy
124,940
+6,011
+5% +$680K 0.84% 41
2018
Q2
$12.5M Sell
118,929
-957
-0.8% -$96.3K 0.84% 43
2018
Q1
$11.2M Sell
119,886
-64
-0.1% -$5.82K 0.76% 47
2017
Q4
$10.5M Buy
119,950
+4,105
+4% +$366K 0.7% 54
2017
Q3
$10.2M Buy
115,845
+2,325
+2% +$197K 0.73% 50
2017
Q2
$9.25M Buy
+113,520
New +$8.63M 0.66% 54

Other funds holding STE

Boston Financial Management's STE Position: Q4 2024 in Review

Boston Financial Management reduced its Steris (STE) stake by 1.7% in Q4 2024, selling an estimated $774K and leaving 199,454 shares worth $41M. The position accounts for 1.24% of the portfolio, ranked #20.

Boston Financial Management first reported a position in STE in Q2 2017 and has held it in 31 quarters since. The position peaked at $52.8M in Q4 2021. 766 funds tracked by Wall St. Rank hold STE as of Q4 2024.

  • Boston Financial Management held 199,454 shares of Steris worth $41M as of Q4 2024.
  • Boston Financial Management sold 3,528 Steris shares in Q4 2024, an estimated $774K.
  • Steris made up 1.24% of Boston Financial Management's portfolio in Q4 2024, its #20 holding.
  • Boston Financial Management first reported a position in Steris in Q2 2017 and has held it in 31 quarters since.
  • Boston Financial Management's Steris position peaked at $52.8M in Q4 2021.
  • 766 funds tracked by Wall St. Rank held Steris as of Q4 2024.

Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.